日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Adopting the estimand framework in prophylactic vaccine trials

在预防性疫苗试验中采用估计量框架

Beckers, Francois; Karkada, Naveen; Yang, Ye; Scott, John; Huang, Lei; Klinglmüller, Florian; Fay, Michael P; Englert, Stefan; Spiessens, Bart; Van Dromme, Ilse; Shekar, Tulin; Zhou, Honghong; Deng, Qiqi; Casula, Daniela; Janes, Holly; Moulton, Lawrence H

Why estimands are needed to define treatment effects in clinical trials

为什么临床试验中需要估计量来定义治疗效果

Keene, Oliver N; Lynggaard, Helle; Englert, Stefan; Lanius, Vivian; Wright, David

First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma

布地加利单抗(一种抗PD-1抑制剂)在非小细胞肺癌和头颈部鳞状细胞癌患者中的首次人体I期研究

Italiano, Antoine; Cassier, Philippe A; Lin, Chia-Chi; Alanko, Tuomo; Peltola, Katriina J; Gazzah, Anas; Shiah, Her-Shyong; Calvo, Emiliano; Cervantes, Andrés; Roda, Desamparados; Tosi, Diego; Gao, Bo; Millward, Michael; Warburton, Lydia; Tanner, Minna; Englert, Stefan; Lambert, Stacie; Parikh, Apurvasena; Afar, Daniel E; Vosganian, Gregory; Moreno, Victor

Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181)

基于模型指导的抗PD-1抗体布地利单抗(ABBV-181)给药方案及I期临床试验结果

Powderly, John; Spira, Alexander; Kondo, Shunsuke; Doi, Toshihiko; Luke, Jason J; Rasco, Drew; Gao, Bo; Tanner, Minna; Cassier, Philippe A; Gazzah, Anas; Italiano, Antoine; Tosi, Diego; Afar, Daniel E; Parikh, Apurvasena; Engelhardt, Benjamin; Englert, Stefan; Lambert, Stacie L; Kasichayanula, Sreeneeranj; Mensing, Sven; Menon, Rajeev; Vosganian, Gregory; Tolcher, Anthony

Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials-Application of the Estimand Framework

评估 COVID-19 对临床试验目标的影响及肿瘤临床试验分析——估计框架的应用

Degtyarev, Evgeny; Rufibach, Kaspar; Shentu, Yue; Yung, Godwin; Casey, Michelle; Englert, Stefan; Liu, Feng; Liu, Yi; Sailer, Oliver; Siegel, Jonathan; Sun, Steven; Tang, Rui; Zhou, Jiangxiu

Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.

胰岛素和甘精胰岛素对 2 型糖尿病患者循环内皮祖细胞生长和数量的影响:一项部分双盲、随机、三臂单中心研究

Oikonomou Dimitrios, Kopf Stefan, von Bauer Rüdiger, Djuric Zdenka, Cebola Rita, Sander Anja, Englert Stefan, Vittas Spiros, Hidmark Asa, Morcos Michael, Korosoglou Grigorios, Nawroth Peter P, Humpert Per M

Improvements in gait characteristics after intensive resistance and functional training in people with dementia: a randomised controlled trial

痴呆症患者接受强化阻力训练和功能训练后步态特征的改善:一项随机对照试验

Schwenk, Michael; Zieschang, Tania; Englert, Stefan; Grewal, Gurtej; Najafi, Bijan; Hauer, Klaus

Sensor-derived physical activity parameters can predict future falls in people with dementia

传感器衍生的身体活动参数可以预测痴呆症患者未来跌倒的风险。

Schwenk, Michael; Hauer, Klaus; Zieschang, Tania; Englert, Stefan; Mohler, Jane; Najafi, Bijan

Stress mediators and immune dysfunction in patients with acute cerebrovascular diseases.

急性脑血管疾病患者的应激介质和免疫功能障碍

Liesz Arthur, Rüger Holger, Purrucker Jan, Zorn Markus, Dalpke Alexander, Möhlenbruch Markus, Englert Stefan, Nawroth Peter P, Veltkamp Roland

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555)

结肠癌伴同步不可切除转移(UICC IV期)患者在接受全身治疗前切除原发肿瘤与不切除原发肿瘤的比较:SYNCHRONOUS——一项随机对照多中心试验(ISRCTN30964555)

Rahbari, Nuh N; Lordick, Florian; Fink, Christine; Bork, Ulrich; Stange, Annika; Jäger, Dirk; Luntz, Steffen P; Englert, Stefan; Rossion, Inga; Koch, Moritz; Büchler, Markus W; Kieser, Meinhard; Weitz, Jürgen